Recombinant Factor VIIa Variant 813d
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Factor VIIa Variant 813d, covering 2017-04-06 to 2017-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia [Phase 1]